Long term (21-day) treatment with antidepressants induces a decrease in P-adrenergic and serotoninz (5HTz) receptor binding in rat brain frontal cortex. Since hormone imbalances are known to be associated with affective illness, the present study was undertaken to determine whether sex hormones influence these alterations in neurotransmitter receptor binding. Using receptor binding assays, we found that castration abolishes the decline in the concentration of 5-HTZ, but not padrenergic, receptors brought on by chronic imipramine or iprindole treatment in both male and female rats. In contrast, the receptor responses to trazodone, mianserin, and pargyline were not influenced by surgery. Furthermore, mianserin was found to reduce /3-adrenergic binding in intact females, but not males, suggesting a sex-related specificity with regard to the response to this agent. Testosterone and estrogen, but not dihydrotestosterone, reversed the effects of castration in males, suggesting that the interaction between the steroids and antidepressants is mediated through estrogenic, rather than androgenic, receptors. The results indicate that the receptor responses to some antidepressant drugs is dependent, at least in part, on the hormonal state of the animal.
Alterations in monoaminergic transmission appear to be related to the symptoms of depression (Schildkraut, 1965; Shopsin et al., 1974; Enna et al., 1981a) . This theory is partially based on the fact that the predominant neurochemical effect of most antidepressants appears to be a modification of catecholamine and indolamine activity. For example, tricyclic antidepressants block transmitter uptake, whereas pargyline inhibits monoamine metabolism.
While alterations in presynaptic processes are undoubtedly crucial in mediating the antidepressant action of some agents, more recent data indicate that these drugs are also capable of influencing neurotransmission by modifying postsynaptic receptor integrity and function (Peroutka et al., 1977; Snyder and Yamamura, 1977; Richelson, 1978; Enna et al., 1981b at histamine, a-adrenergic, and cholinergic muscarinic receptors. Moreover, long term administration of antidepressants can modify receptor number and function for a variety of monoamine systems, with P-adrenergic and serotonins (5-HTz) receptors being particularly vulnerable in this regard (Banerjee et al., 1977; Maggi et al., 1980; Peroutka and Snyder, 1980a; Vetulani and Sulser, 1975; Enna et al., 1981b) . Indeed, chronic administration of most antidepressants will, under the proper conditions, decrease the number or functional activity of brain fiadrenergic receptors as well as reduce the quantity of 5-HT2 binding sites. These findings are particularly intriguing since the average time necessary to observe these changes in receptor number is similar to the amount of time purported to be necessary for observing a subjective clinical response (Denber, 1975) . Importantly, similar receptor alterations do not occur following long term treatment with other psychoactive drugs (Peroutka and Snyder, 1980a) .
While there is little evidence to link changes in receptor number directly to modifications in behavior, the specificity of this neurochemical response with regard to antidepressants and the temporal correlation between the appearance of the receptor changes and clinical response suggest that the decreases in /3-adrenergic and 5-HTr receptor binding and function may be an index of anti-354 depressant efficacy. Using this approach, it has been found that the imipramine-induced decline in 5-HT2 receptor binding does not occur in ovariectomized rats, suggesting that sex hormones may play a vital role in the molecular, and possibly clinical, response to this drug (Kendall et al., 1981c) .
In the present study, this interaction is examined in more detail to establish specificity with respect to the hormones involved, the antidepressants, and the sex of the animal. The results indicate that the response to all antidepressants is not affected similarly by gonadectomy and that males and females are affected equally. Furthermore, hormone replacement studies reveal that estrogen, rather than progesterone or testosterone, is the most likely mediator of this receptor response to some antidepressants.
Materials
and Methods Surgical procedures.
Sprague-Dawley rats (150 to 175 gm) of both sexes were used for all experiments, and surgical procedures were conducted using ether anesthesia. Bilateral ovariectomies were performed through a single midline incision on the dorsal surface of the animal. The success of surgery was verified at autopsy by measuring uterine weight. Male animals were castrated by surgical removal of both testes. All animals were housed normally (six to a cage) with a 12-hr light-dark cycle and were allowed free access to food and water.
Animals were killed by decapitation at various times after surgery and drug treatment.
Brains were removed rapidly, dissected on ice, frozen on dry ice, and stored at -20°C until assayed.
Hormone and drug treatment. For hormone treatments, animals were injected once daily, subcutaneously, with 17/3-estradiol (10 pg/animal/day), testosterone propionate
(1 mg/animal/day), or dihydrotestosterone (DHT; 1 mg/animal/day).
All hormones were dissolved in a minimum volume of absolute ethanol, after which sesame oil was added and the mixture was heated at 60°C for 1 hr. Hormone treatments were initiated routinely 24 hr after surgery and were continued throughout the study period. Sham-operated control animals received an equivalent volume of vehicle.
With antidepressants, treatment began no sooner than 7 days after surgery, and the animals received a single daily intraperitoneal injection of the drug throughout the treatment period. All antidepressants were dissolved in saline or distilled water just prior to injection and control animals received an equivalent volume of vehicle.
All hormone and antidepressant drug treatments were performed at the same time of day (3 to 4 P.M.), and the animals were killed 24 hr following the last injection.
Receptor binding assays. P-Adrenergic and 5-HT2 receptor binding in frontal cortex were conducted using previously published procedures (Bylund and Snyder, 1976; Peroutka and Snyder, 1979) . Briefly, for p receptor binding, the brain tissue was homogenized in 10 vol of chilled 0.05 M Tris-HCl buffer (pH 8.0 at 25°C) and, following centrifugation at 48,000 X g for 10 min at 4°C the supernatant was discarded and the pellet was resuspended in buffer as above. After a second centrifugation, the washed pellet was resuspended a final time to a concentration of 0.5 to 1.0 mg of protein/ml. Portions of this homogenate were added, in triplicate, to culture tubes containing 0.2 nM [3H]dihydroalprenolo1 (["HI DHA; 4.5 Ci/mmol). Nonspecific binding was determined by conducting the assay in the presence of 5 PM propran-0101. The final volume of the mixture was 1 ml, and the assay was conducted by incubating the membrane suspension at 25'C for 30 min. The reaction was terminated by filtration over glass fiber filters (GF/C) maintained under reduced pressure. After rinsing with cold buffer, the filters were placed into scintillation vials containing 10 ml of Aquasol (New England Nuclear) and then agitated for 3 hr at room temperature, and radioactivity was quantified using liquid scintillation spectrometry. For 5-HTz receptor binding, the tissue was homogenized and resuspended as above using 0.05 M Tris-HCl (pH 7.5 at 25°C). Following the second centrifugation, the pellet was resuspended in buffer and the homogenate was incubated at 37°C for 10 min. After a final centrifugation, the tissue was resuspended in buffer containing 1 gm/liter of ascorbic acid, 1.96 mg/liter of pargyline, and 0.59 gm/liter of CaC12. The homogenate was incubated at 37°C for 15 min and then cooled on ice for 15 min. For assay, portions (0.5 to 1 mg of protein) of this homogenate were placed, in triplicate, into culture tubes containing 0.3 nM ["Hlspiroperidol (29 Ci/mmol) in the presence and absence of 100 pM serotonin (blank). The final incubation volume was 1 ml and the samples were incubated at 37°C for 15 min, with the reaction terminated and radioactivity quantified as above. For receptor binding site saturation studies, membranes were incubated in the presence of various concentrations of ["Hlspiroperidol (0.1 to 4 nM) in the presence and absence of unlabeled serotonin.
For both P-adrenergic and 5-HTz binding assays, specific receptor binding was defined as the amount of radioactivity displaced by the unlabeled ligand. Protein was assayed by the method of Lowry et al. (1951) .
Statistics. The significance of the difference between means was evaluated by a one-way analysis of variance and a Student Newman-Keuls multiple range test (n I 6). Differences were considered statistically significant when p I 0.05.
Drugs and chemicals. All radioisotopes were purchased from New England Nuclear (Boston, MA 
Results
The influence of castration on imipramine-induced receptor modifications in female rat brain. In an earlier report (Kendall et al., 1981c) , data were presented to indicate that ovariectomy prevents the imipramine-induced reduction in 5-HTz, but not P-adrenergic, receptor binding in rat brain frontal cortex. In order to determine whether castration altered the time course of the changes in receptor binding, groups of ovariectomized and sham- Vol. 2, No. 3, Mar. 1982 operated controls were treated with 10 mg/kg of imipramine once daily for various lengths of time and cortical ,&adrenergic and 5-HT2 receptor binding were evaluated during the course of treatment (Fig. 1) . In sham-operated controls, P-adrenergic receptor binding was significantly and maximally reduced (20%) during the first 10 days of treatment as compared to untreated animals. On the other hand, between 10 and 21 days of treatment were necessary before a significant reduction (47%) in 5-HT2 receptor binding was noted in these animals. Ovariectomy had no effect on either the time course or the extent 90 of the reduction in ,8-adrenergic binding, but ovariectomy prevented the reduction in 5-HTz binding which was observed in sham-operated controls (Fig. 1) .
Receptor binding saturation analysis revealed that the imipramine-induced decrease in 5-HT2 receptor binding in intact animals was due entirely to a reduction in the concentration of binding sites (B,,,) , with no change in receptor affinity (&) (Fig. 2) . Thus, the B,,, for 5-HTa receptor binding in frontal cortex of intact imipraminetreated animals was 40% lower than that found in untreated controls. Saturation analysis also indicated that Imipramine (10 mg/kg, once daily, i.p.) treatment was initiated in the different groups at various times after surgery such that sacrifice occurred 28 days following castration in all cases. All animals were decapitated on the same day, 24 hr after the last drug treatment. /?-Adrenergic and 5-HTz receptor binding were analyzed in frontal cortex using ["HIDHA and [:'H] (Banerjee et al., 1977) .
The influence of castration on 5-HT2 and P-adrenergic receptor reductions induced by a variety of antidepressants in male and female rats. In order to determine whether the apparent interaction between sex steroids and 5-HTz receptors is peculiar for imipramine, the influence of castration on the 5-HTz receptor response to a variety of other antidepressants was examined in both male and female rats (Table I) . With respect to females, only imipramine and iprindole treatment were modified significantly by castration, with trazodone, mianserin, and pargyline all inducing similar, and significant, reductions in 5-HT2 binding in both intact and castrate animals. In intact females, 5-HTz receptor binding was decreased almost 50% following 21 days of continuous treatment with iprindole, whereas with castrates, the drug reduced binding only 15%. While fewer drugs were tested, a similar pattern of response was observed with male rats (Table I) . Thus, with castrate males, there was no significant reduction in cortical 5-HT2 receptor binding following 21 days of treatment with imipramine (10 mg/kg) or iprindole (10 mg/kg), whereas both drugs induced a 30 to 50% reduction in binding in intact animals. However, as with females, castration had no influence on the reduction in 5-HT2 receptor binding observed following chronic treatment with mianserin.
With regard to the ,&adrenergic receptor system, only imipramine, mianserin, and pargyline caused significant reductions in binding in intact females at the doses and during the time period (21 days) examined (Table II) . As reported previously (Kendall et al., 1981c) , castration had no effect on the imipramine-induced decline in P-adrenergic binding in females, and the present results indicate that pargyline is similarly unaffected. However, castration significantly attenuated the P-adrenergic receptor response to mianserin in the female rats, with no significant reduction observed in the operated animals although there was over a 20% decline in binding in the shamoperated controls (Table II) .
With males, imipramine was the only drug tested that induced a significant decline in ,f3-adrenergic receptor binding using this treatment protocol and, as with fe- males, castration had no influence on this response. In contrast to females, however, mianserin had no significant effect on /3 receptor binding in intact males. For both neurotransmitter receptor binding systems, no significant differences were noted in base line binding between male and female rats, either in the intact or castrate groups (Tables I and II) .
Reversibility of the castration effect. Earlier work has shown that the effect of castration on the imipramineinduced decline in 5-HTz receptor binding in female rats is reversed by the administration of estrogen or progesterone (Kendall et al., 1981c) . In the present study, the reversibility in male rats was explored (Table III) . Once again, chronic (21-day) treatment with imipramine was observed to have no effect on 5-HTz receptor binding in castrate males. However, co-administration of testosterone (1 mg/animal/day) or estradiol (10 pg/animal/day) once daily to castrate males treated with the antidepressant resulted in a significant reduction in binding. On the other hand, DHT
(1 mg/animal/day) treatment was unable to overcome the castration effect (Table III) . Other experiments revealed that, when given alone to either castrate or intact males or in combination with imipramine in intact animals, none of these hormones had any significant influence on either base line /3-adrenergic or 5-HTz receptor binding or imipramine-induced changes in these systems (data not shown).
The effect of sex steroids on ,B-adrenergic and 5-HTz receptor binding in vitro. To examine whether sex hormones can influence ligand binding to /?-adrenergic and 5-HTz receptor sites directly, receptor binding was analyzed in the presence and absence of 1 PM P-estradiol, progesterone, or testosterone using brain membranes obtained from intact untreated female rats. In these experiments, the influence of hormones on the potency of receptor site agonists and antagonists to displace radioligand was explored. In no case did any of the hor- (Kendall et al., 1981a, b, c; Enna et al., 1981 a, b; Wagner and Davies, 1980; Rainbow et al., 1980; Savageau and Beatty, 1981; Hruska and Silbergeld, 1980; Chiodo et al., 1981) . Since antidepressants may act, in part, by modifying the number and function of certain brain neurotransmitter receptors (Enna et al., 1981b ) and since hormone imbalances are known to be associated with a variety of depressive disorders (Prange et al., 1977; Halbreich et al., 1979; deWied, 1980; S&lesser et al., 1980) , studies have been undertaken to determine whether the neurochemical response to these drugs might be dependent upon the hormonal state of the animal. Previous results have indicated that the imipramine-induced decline in 5-HT2 receptor binding in female rat brain is dependent upon the presence of sex steroids (Kendall et al., 1981b, c) . The present results confirm and extend this initial observation.
The time course study revealed that castration completely prevents the imipramine-induced decline in 5-HT2 binding during the 21-day treatment without affecting the response in ,l3-adrenergic receptors. Receptor binding saturation analysis indicates that castration prevents the antidepressant-induced reduction in the concentration of 5-HTz receptor sites without influencing the affinity of the receptor for the radioligand. Furthermore, these experiments revealed that the decrease in P-adrenergic receptor binding precedes the 5-HT2 receptor decline with the former occurring within the first 10 days of treatment, whereas the latter required 10 to 20 days of drug administration. While it might be argued that the time course of the reduction in 5-HTz receptor binding better coincides with the reported therapeutic effect than the change in p receptors, the variability in the time to clinical response is too great to support such speculation.
The interaction between gonadal hormones and antidepressants also appears to be somewhat drug specific. Thus, of the antidepressants tested, only imipramine and iprindole were influenced significantly by castration, whereas the 5-HT2 receptor response to trazodone, mianserin, and pargyline was unaffected. With regard to the 5-HTz receptor, both male and female rats appeared to respond in a similar manner. In contrast, /3-adrenergic receptor modifications appeared to be more resistant to hormonal manipulation. However, although mianserin was incapable of decreasing fi-adrenergic receptor binding in intact male rats under the present conditions, it did cause a significant decline in intact females, suggesting that females may be more sensitive to the action of this drug. Furthermore, castration modified the mianserin-induced P-adrenergic receptor decline in females, indicating that, with some drugs at least, sex hormones may influence P-adrenergic responses.
While it is conceivable that the reduction in receptor binding noted following long term treatment with antidepressants may be due to the presence of residual drug in brain membranes, others have shown that this is probably not an important factor under the conditions used in the present experiments (Peroutka and Snyder, 1980b) . Moreover, it could be argued that the apparent decrease in the effectiveness of some drugs to alter receptor binding in castrate animals may be the result of a change in drug metabolism rather than to some receptor interaction at a molecular level. This too would seem unlikely since, in all cases, either P-adrenergic or 5HT2 receptor binding is affected, not both as might be expected if the drug was more rapidly metabolized or excreted. Furthermore, it also has been reported that, for imipramine at least, the drug-induced decline in 5-HT2 receptor binding is observed in cerebral cortex but not hippocampus, which also would argue against a significant alteration in the circulating levels of the drug (Kendall et al., 1981c) . Finally, castration has been shown to have a negligible effect on the hepatic metabolism of imipramine at least in female rats (Skett et al., 1980) . Accordingly, the differential effect of castration on the receptor responses to various antidepressant drugs suggests that, while virtually all antidepressants are capable of reducing the number of 5-HTz receptors, the molecular mechanisms involved may differ.
Further evidence that sex hormones are crucial for this receptor change was provided by the hormone replacement experiments. Thus, with males, treatment with testosterone or estradiol overcame the effects of castration. Importantly, DHT was found to be inactive in this regard. This suggests that estrogenic rather than androgenie receptors are the most likely mediators of this response since, while a significant amount of testosterone is aromatized to estrogen, little DHT is metabolized to this steroid (McEwen, 1981 ).
The precise mechanism whereby sex hormones influence drug-induced changes in neurotransmitter receptor number is unknown. While it is possible that these steroids may modify binding and function by directly interacting with the receptor recognition site, the fact that they failed to modify receptor binding when added in vitro would seem to argue against such an action. Alternatively, it is conceivable that the sex hormones may influence receptor turnover by affecting protein synthesis, although this too seems unlikely in light of the fact that not all antidepressants are affected similarly. It is possible, however, that steroids could have a selective effect on the synthesis of specific proteins.
A third possibility is that the hormones may modify some aspect of neurotransmitter turnover, release, or reuptake and, in this way, indirectly influence the change in receptor number since the receptor response to many antidepressants is undoubtedly dependent upon presynaptic activity. Indeed, it is well established that gonadal hormones can influence a variety of presynaptic processes (Luine et al., 1980; Beattie et al., 1972; Holzbaurer and Youdim, 1973; Hackman et al., 1973) .
A final possibility is that the neurotransmitter receptor binding changes observed in this study are secondary to an alteration in hypothalamic-pituitary hormone release induced by castration. For example, prolactin levels are regulated to some extent by estradiol, and prolactin is known to modify neurotransmitter turnover in brain (McEwen, 1981) . Furthermore, adrenocorticotropic hormone secretion is reduced in ovariectomized animals (Coyne and Kitay, 1969) .
Regardless of the precise mechanism, the present data indicate that antidepressant-induced modifications in neurotransmitter receptor binding sites are dependent upon circulating levels of sex hormones and that the molecular mechanism by which antidepressants decrease recognition site binding may differ within this drug class. If these alterations in receptor binding are related to therapeutic efficacy, these findings may provide a clue as to why a significant number of patients fail to respond to antidepressant therapy. More precise information about the interactions among hormones, antidepressants, and neurotransmitter receptors may provide a better understanding of the mechanism of action of this drug class at a molecular level and more clearly define the neurochemical and hormonal influences in the etiology of depression.
